The company’s board has approved the appointment of Manish Anandani as Managing Director and Chief Executive Officer, effective 28 September 2026.
During Prabha Narasimhan’s four-year...
Tambe, as the first CEO of the integrated Biocon, will lead the combined platform spanning biosimilars and generics, strengthening the company’s ability to operate...